RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
1-Year Return
18.15%
This Quarter Return
-14.25%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$5.67B
AUM Growth
-$1.54B
(-21%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
45.45%
Holding
105
New
10
Increased
9
Reduced
7
Closed
8
Top Buys
| 1 |
BLU
BELLUS Health Inc.
BLU
|
$82.4M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$55.9M |
| 3 |
LIAN
LianBio American Depositary Shares
LIAN
|
$47.2M |
| 4 |
Relmada Therapeutics
RLMD
|
$45.1M |
| 5 |
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
|
$34.8M |
Top Sells
| 1 |
Atea Pharmaceuticals
AVIR
|
$190M |
| 2 |
TG Therapeutics
TGTX
|
$35.9M |
| 3 |
VERV
Verve Therapeutics
VERV
|
$21M |
| 4 |
CytomX Therapeutics
CTMX
|
$17.8M |
| 5 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$10.2M |
Sector Composition
| 1 | Healthcare | 98.88% |
| 2 | Financials | 0.78% |
